Synlett 2007(16): 2587-2589  
DOI: 10.1055/s-2007-986649
LETTER
© Georg Thieme Verlag Stuttgart · New York

Concise Synthesis of Novel 2,6-Diazaspiro[3.3]heptan-1-ones and Their Conversion into 2,6-Diazaspiro[3.3]heptanes

Michael J. Stocks*, Daniel Hamza, Garry Pairaudeau, Jeffrey P. Stonehouse, Philip V. Thorne
Department of Medicinal Chemistry, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leicestershire, LE11 5RH, UK
Fax: +44(1509)645571; e-Mail: mike.stocks@astrazeneca.com;
Further Information

Publication History

Received 21 May 2007
Publication Date:
12 September 2007 (online)

Abstract

A concise synthesis, amenable to library production of 2,6-diazaspiro[3.3]heptan-1-ones and their subsequent conversion into 2,6-diazaspiro[3.3]heptanes is reported.

    References and Notes

  • For some recent applications of parallel synthesis in drug design, see:
  • 1a Habashita H. Kokubo M. Hamano S.-I. Hamanaka N. Toda M. Shibayama S. Tada H. Sagawa K. Fukushima D. Maeda K. Mitsuya H. J. Med. Chem.  2006,  49:  4140 
  • 1b Edwards PJ. IDrugs  2006,  9:  347 
  • 1c Lu S.-F. Chen B. Davey D. Dunning L. Jaroch S. May K. Onuffer J. Phillips G. Subramanyam B. Tseng J.-L. Wei RG. Wei M. Ye B. Bioorg. Med. Chem. Lett.  2007,  17:  1883 
  • To the best of our knowledge the azetidine-derived spirocyclic β-lactam (2,6-diazaspiro[3.3]heptan-1-one) ring system has not previously been prepared in the chemical literature. Proline-derived spirocyclic β-lactams are represented in the chemical literature and are useful as β-turn mimetics. For examples, see:
  • 2a Macías A. Morán Ramallal A. Alonso E. del Pozo C. González J. J. Org. Chem.  2006,  71:  7721 
  • 2b Bittermann H. Gmeiner P. J. Org. Chem.  2006,  71:  97 
  • 2c Khasanov AB. Ramirez-Weinhouse MM. Webb TR. Thiruvazhi M. J. Org. Chem.  2004,  69:  5766 
  • 2d Alonso E. Lopez-Ortiz F. del Pozo C. Peralta E. Macias A. Gonzalez J. J. Org. Chem.  2001,  66:  6333 
  • For recent syntheses of piperidine-derived spirocyclic β-lactams, see:
  • 2e Arnott G. Clayden J. Hamilton SD. Org. Lett.  2006,  8:  5325 
  • 2f Macias A. Alonso E. del Pozo C. Gonzalez J. Tetrahedron Lett.  2004,  45:  4657 
  • 2g Clayden J. Hamilton SD. Mohammed RT. Org. Lett.  2005,  7:  3673 
  • 3a Bartholomew D. Stocks MJ. Tetrahedron Lett.  1991,  32:  4795 
  • 3b

    Optimised experimental conditions for the synthesis of 4 from the readily available precursor 3 are given. To cold EtOH (250 mL) at 0-5 °C was added Na metal (25.5 g, 1.5 equiv). The solution was allowed to warm to r.t. and was stirred for 1 h. To the reaction mixture was added a solution of compound 3 (190 g) in EtOH (100 mL) and the reaction was stirred for 14 h at r.t. The reaction mixture was slowly poured into ice-cold H2O and extracted with PE (3 × 250 mL). The combined organic layers were washed with brine, dried over Na2SO4, and concentrated. The crude reaction product (110 g) was dissolved in toluene (800 mL) and K2CO3 (110 g, 2.2 equiv) added. The reaction mixture was refluxed for 16 h, cooled, and filtered. The residue was purified over silica gel eluting with 8% EtOAc in isohexane to give 1-benzyl-3-chloromethylazetidine-3-carboxylic acid ethyl ester (60 g) as pale yellow liquid. 1H NMR (300 MHz, CDCl3): δ = 7.37-7.22 (m, 5 H), 4.23 (q, J = 7.1 Hz, 2 H), 4.05 (s, 2 H), 3.64 (s, 2 H), 3.43 (d, J = 8.5 Hz, 2 H), 3.31 (d, J = 8.5 Hz, 2 H), 1.29 (t, J = 7.1 Hz, 3 H).

  • The free azetidine 9 can be readily functionalised by reaction with, for example:
  • 7a

    acid chlorides to generate amides;

  • 7b

    aldehydes to generate N-substituted alkyl amines;

  • 7c

    isocyanates to generate ureas and

  • 7d

    sulfonyl chlorides to generate sulfonamides under standard reaction conditions.

  • For a recent synthesis of this interesting ring system, see:
  • 9a Hillier MC. Chen C.-Y. J. Org. Chem.  2006,  71:  7885 
  • 9b Engel W, Eberlein W, Trummlitz G, Mihm G, Doods H, Mayer N, and De Jonge A. inventors; EP  417631.  For an application of the use of 2,6-diaza-spiro[3.3]heptanes in drug discovery, see:
  • For some examples of the reduction of β-lactams to azetidines, see:
  • 10a Brayer JL. Alazard JP. Thal C. Tetrahedron  1990,  46:  5187 
  • 10b Ojima I. Zhao M. Yamato T. Nakahashi K. Yamashita M. Abe R. J. Org. Chem.  1991,  56:  5263 
  • 10c Yamashita M. Ojima I. J. Am. Chem. Soc.  1983,  105:  6339 
  • 10d Ojima I. Yamato T. Nakahashi K. Tetrahedron Lett.  1985,  26:  2035 
  • 11a Van Brabandt W. De Kimpe N. Synlett  2006,  2039 
  • 11b Van Elburg PA. Reinhoudt DN. Heterocycles  1987,  26:  437 
4

Hydrolysis of 4 was previously reported to afford 6; see ref. 3 for details.

5

Compound 7 can be stored under dry nitrogen for up to four weeks.

6

Preparation of 1a
To a stirred suspension of NaH (60% in mineral oil, 0.349 g) in THF (30 mL) was added 1-benzyl-3-chloromethyl-azetidine-3-carboxylic acid phenylamide (2.5 g) in THF (15 mL) and the mixture stirred for 2 h at r.t. Then, H2O was added and the mixture was extracted with EtOAc. The organic phase was dried with anhyd MgSO4, filtered, and concentrated. The residue was purified by flash column chromatography eluting with EtOAc to give 6-benzyl-2-phenyl-2,6-diazaspiro[3.3]heptan-1-one (2.14 g) as a white solid after recrystallisation from Et2O-i-hexane; mp 122-123 °C. MS: m/z = 279.2 [M + H]+; 99.3% purity. Anal. Calcd. for: C. 77.67; H, 6.52; N, 10.06. Found: C, 77.57; H, 6.55; N, 10.13. 1H NMR (400 MHz, CDCl3): δ = 7.35-7.24 (m, 9 H), 7.10-7.06 (m, 1 H), 3.86 (s, 2 H), 3.66 (s, 2 H), 3.61 (d, J = 1.5 Hz, 4 H). 13C NMR (100 MHz, CDCl3): δ = 165.8, 138.0, 137.4, 129.1, 128.5, 128.4, 127.2, 123.9, 116.3, 62.9, 58.2, 51.6, 50.3.

8

Analysis of 2-phenyl-2,6-diazaspiro[3.3]heptan-1-one (9): mp 149-150 °C. GC-MS: m/z = 188 [M]+; 100% pure. Anal. Calcd for: C, 70.19; H, 6.43; N, 14.79. Found: C, 70.05; H, 6.51; N, 14.79. 1H NMR (400 MHz, CDCl3): δ = 7.35-7.30 (m, 4 H), 7.11-7.07 (m, 1 H), 4.27 (d, J = 9.6 Hz, 2 H), 3.86 (s, 2 H), 3.79 (d, J = 9.6 Hz, 2 H), 1.83 (s, 1 H). 13C NMR (100.5 MHz, CDCl3): δ = 166.1, 138.0, 129.1, 124.0, 116.3, 54.1, 51.7, 51.5.

12

The high stoichiometry of the reduction makes this reaction incompatable with library synthesis. However, a new synthesis of 2,6-diazaspiro[3.3]heptanes, amenable to library synthesis, will be communicated separately.

13

Preparation of 2a
To a stirred solution of AlCl3 (0.20 g) in Et2O (3 mL) was added LiAlH4 in Et2O (1 M, 1.49 mL) and the mixture stirred at 40 °C for 15 min before being cooled to r.t. and 6-benzyl-2-phenyl-2,6-diazaspiro[3.3]heptan-1-one (0.139 g) in THF (1 mL) was added. The reaction was warmed to 40 °C for 1 h before being cooled to r.t. Then, H2O (0.2 mL), followed by 15% NaOH solution (0.2 mL), and finally H2O (0.6 mL) were added. The mixture was stirred for 15 min and filtered. The solution was concentrated and the residue purified by chromatography on silica gel eluting with 2-5% 0.7 N NH3 in MeOH in CH2Cl2 to afford 2-benzyl-6-phenyl-2,6-diazaspiro[3.3]heptane (0.077 g) as an oil. MS: m/z = 265.17 [M + H]+. 1H NMR (400 MHz, CDCl3): δ = 7.34-7.18 (m, 7 H), 6.73 (t, J = 7.5 Hz, 1 H), 6.44 (d, J = 7.0 Hz, 2 H), 3.94 (s, 4 H), 3.60 (s, 2 H), 3.40 (s, 4 H). 13C NMR (100 MHz, CDCl3): δ = 151.4, 137.7, 128.8, 128.4, 128.3, 127.1, 117.6, 111.5, 64.4, 63.5, 62.2, 34.7.